Quest Diagnostics (DGX) Surpasses Q3 Earnings and Revenue Estimates

分组1 - Quest Diagnostics reported quarterly earnings of $2.6 per share, exceeding the Zacks Consensus Estimate of $2.51 per share, and showing an increase from $2.3 per share a year ago, resulting in an earnings surprise of +3.59% [1][2] - The company achieved revenues of $2.82 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.45%, compared to $2.49 billion in the same quarter last year [2] - Quest Diagnostics has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2][6] 分组2 - The stock has gained approximately 26.2% since the beginning of the year, outperforming the S&P 500's gain of 14.5% [3] - The current consensus EPS estimate for the upcoming quarter is $2.42 on revenues of $2.72 billion, and for the current fiscal year, it is $9.74 on revenues of $10.85 billion [7] - The Zacks Industry Rank for Medical - Outpatient and Home Healthcare is in the top 19% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]